Effect of Pyridorin in Patients With Diabetic Nephropathy

Summary

The primary objective of the study is to evaluate the safety and tolerability of Pyridorin (pyridoxamine dihydrochloride) 50 mg given orally twice daily in patients with diabetic kidney disease.

Timeline

Start

2001-10

Primary completion

—

Completion

2003-01

Drugs

Indications